Inventor · disambiguated record
Mingbo Su
Also filed as: SU MINGBO
9 granted patents·6 pending applications·12 citations·filing 2012–2023
78Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS6UNIV ZHEJIANG3BIOPOLAR HONGYE GUANGDONG PHARMACEUTICAL CO LTD2HANGZHOU HEALZEN THERAPEUTICS CO LTD2NAN FAJUN1
Top patents by PatentIndex Score
15 records- 0185US9045491B2Thienyl [3,2-D] pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereofSHANGHAI INST MATERIA MEDICA·Filed 2012·Granted Jun 2, 2015·5 cites·19 claims
- 0282US10822327B22-substituted aromatic ring-pyrimidine derivative and preparation and application thereofUNIV ZHEJIANG·Filed 2017·Granted Nov 3, 2020·4 cites·9 claims
- 0372US9216962B2Thiazole compounds, methods for preparation and use thereofNAN FAJUN·Filed 2012·Granted Dec 22, 2015·3 cites·13 claims
- 0457US2023295144A12-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereofUNIV ZHEJIANG·Filed 2023·Application pending·0 cites
- 0557US2025042862A1Aromatic heterocyclic compound and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0653US2025034135A1Anti-apoptotic protein bcl-2 inhibitor, pharmaceutical composition and uses thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0751US11591325B22-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereofUNIV ZHEJIANG·Filed 2017·Granted Feb 28, 2023·0 cites·1 claims
- 0850US2024360146A1Bruton's tyrosine kinase and mutant degrader, composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0946US2023167114A1Macrocyclic jak inhibitor and use thereofBIOPOLAR HONGYE GUANGDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1046US2023203059A1Macrocyclic jak inhibitor and uses thereofBIOPOLAR HONGYE GUANGDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1143US10766889B2Aryl-2,2′-tandem bisthiazole compound and preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Sep 8, 2020·0 cites·19 claims
- 1241US10392401B2Crystal form A of compound and preparation method thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2016·Granted Aug 27, 2019·0 cites·9 claims
- 1337US11873292B2Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Jan 16, 2024·0 cites·10 claims
- 1437US10836743B2Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Nov 17, 2020·0 cites·12 claims
- 1529US9643941B22,2′-tandem dithiazole compound, preparation method therefor, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted May 9, 2017·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →